Clinical trial
Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis - An Investigator-initiated, Randomized, Placebo-controlled, Double-blind Clinical Trial
NCT04743570 is registered in ClinicalTrials.gov with Asbjørn Mohr Drewes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis - An Investigator-initiated, Randomized, Placebo-controlled, Double-blind Clinical Trial
- Lead sponsor
- Asbjørn Mohr Drewes
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 14, 2021
- Completion date
- April 20, 2023
- Enrollment
- 105 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis